Literature DB >> 12409393

Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.

Shawn D Aaron1, Wendy Ferris, Karam Ramotar, Katherine Vandemheen, Francis Chan, Raphael Saginur.   

Abstract

Evidence suggests that Pseudomonas aeruginosa bacteria form biofilms within the airways of adults with cystic fibrosis (CF). The objective of this study was to determine whether clinical isolates of P. aeruginosa recovered from adults with CF have similar susceptibilities to individual antibiotics and to antibiotic combinations when grown as adherent monolayers or as biofilms compared to when they are grown using planktonic methods. Twelve multiresistant P. aeruginosa isolates, one mucoid and one nonmucoid from each of six CF patients, were grown conventionally under planktonic conditions, as adherent bacterial monolayers, and as biofilms. Each bacterial isolate remained genotypically identical despite being cultured under planktonic, adherent, or biofilm growth conditions. Isolates grown as adherent monolayers and as biofilms were less susceptible to bactericidal killing by individual antibiotics compared to those grown planktonically. More importantly, biofilm-grown bacteria, but not adherent monolayer-grown bacteria, were significantly less susceptible to two- and three-drug combinations of antibiotics than were planktonically grown bacteria (P = 0.005). We conclude that biofilm-grown bacteria derived from patients with CF show decreased susceptibility to the bactericidal effects of antibiotic combinations than do adherent and planktonically grown bacteria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409393      PMCID: PMC139693          DOI: 10.1128/JCM.40.11.4172-4179.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

Review 1.  Role of biofilms in antimicrobial resistance.

Authors:  R M Donlan
Journal:  ASAIO J       Date:  2000 Nov-Dec       Impact factor: 2.872

Review 2.  New antimicrobials in the management of cystic fibrosis.

Authors:  Niels Høiby
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

3.  Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment.

Authors:  Robert E. W. Hancock; David P. Speert
Journal:  Drug Resist Updat       Date:  2000-08       Impact factor: 18.500

Review 4.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

5.  Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.

Authors:  L Saiman; F Mehar; W W Niu; H C Neu; K J Shaw; G Miller; A Prince
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.

Authors:  S D Aaron; W Ferris; D A Henry; D P Speert; N E Macdonald
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

8.  Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.

Authors:  R S Baltimore; C D Christie; G J Smith
Journal:  Am Rev Respir Dis       Date:  1989-12

9.  Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment.

Authors:  F P Laing; K Ramotar; R R Read; N Alfieri; A Kureishi; E A Henderson; T J Louie
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma.

Authors:  M Dahl; A Tybjaerg-Hansen; P Lange; B G Nordestgaard
Journal:  Lancet       Date:  1998-06-27       Impact factor: 79.321

View more
  44 in total

Review 1.  Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Authors:  Melissa B Miller; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Novel Pseudomonas aeruginosa gene that suppresses tolerance to carbapenems.

Authors:  Kazuko Taniguchi; Tsuneko Ono; Keiji Murakami; Darija Viducic; Sizuo Kayama; Katsuhiko Hirota; Ken Nemoto; Yoichiro Miyake
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.

Authors:  Raphael Saginur; Melissa Stdenis; Wendy Ferris; Shawn D Aaron; Francis Chan; Craig Lee; Karam Ramotar
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.

Authors:  E Caraher; G Reynolds; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

5.  Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

Authors:  Dominic Hill; Barbara Rose; Aniko Pajkos; Michael Robinson; Peter Bye; Scott Bell; Mark Elkins; Barbara Thompson; Colin Macleod; Shawn D Aaron; Colin Harbour
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells.

Authors:  Raquel Garcia-Medina; W Michael Dunne; Pradeep K Singh; Steven L Brody
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  A central composite rotatable design (CCRD) approach to study the combined effect of antimicrobial agents against bacterial pathogens.

Authors:  Fernanda Godoy Santos; Layanne Andrade Mendonça; Hilário Cuquetto Mantovani
Journal:  World J Microbiol Biotechnol       Date:  2015-06-17       Impact factor: 3.312

8.  Dry powder aerosols to co-deliver antibiotics and nutrient dispersion compounds for enhanced bacterial biofilm eradication.

Authors:  S Sommerfeld Ross; S Gharse; L Sanchez; J Fiegel
Journal:  Int J Pharm       Date:  2017-08-04       Impact factor: 5.875

9.  Role of psl Genes in Antibiotic Tolerance of Adherent Pseudomonas aeruginosa.

Authors:  Keiji Murakami; Tsuneko Ono; Darija Viducic; Yoko Somiya; Reiko Kariyama; Kenji Hori; Takashi Amoh; Katsuhiko Hirota; Hiromi Kumon; Matthew R Parsek; Yoichiro Miyake
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

10.  Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.

Authors:  L Dales; W Ferris; K Vandemheen; S D Aaron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-07-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.